Nektar Therapeutics, Rubrik, and SentinelOne Earnings Preview
- March 08th, 2026
- 211 views
Las Vegas, NV / CRWE PRESS RELEASE / March 8, 2026 - Among the companies expected to release financial results on Thursday, March 12, are
Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company focused on developing therapies for autoimmune disorders and cancer, will announce its financial figures for the fourth quarter and the year ended 2025 after the close of U.S. markets. Analysts expect a loss of $3.49 per share on revenue of $10.41 million. $NKTR closed Friday at $70.70, down $1.75, or 2.42%.
Rubrik, Inc. (NYSE: RBRK), a cloud data management and cybersecurity company specializing in data protection, backup, and ransomware recovery solutions, will release its fourth-quarter and fiscal year 2026 results after the closing bell. Wall Street expects a loss of $0.11 per share on revenue of $342.37 million. $RBRK ended Friday at $57.17, up $1.29, or 2.31%.
SentinelOne, Inc. (NYSE: S), a cybersecurity firm known for its AI-powered endpoint security platform, will deliver its fourth-quarter and fiscal year 2026 financial results following the market close. The consensus loss estimate stands at $0.18 per share, with revenue projected to reach $271.16 million. On Friday, $S closed at $14.19, up $0.22, or 1.57%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
June 11th, 2026June 11th, 2026
NJCP Continues to Create Opportunities for Overlooked Athletes Ahead of the 2026 Season
June 11th, 2026NJCP Focuses on the Path Beyond High School for Student-Athletes
June 11th, 2026Treasury Previews Education Freedom Tax Credit Guidance
June 10th, 2026




Member Login